Next week, at the Perth Convention and Exhibition Centre, The Royal Australian and New Zealand College of Psychiatrists (RANZCP) meet for the RANZCP 2023 Congress on the theme of “New Horizons: Connected Futures”
Delegates have been invited to reflect on how interconnectedness is a strength; and connections with each other in personal and professional lives, connections with the diverse cultures in communities, and connection to place with First Nations people.
Looking forward delegates have been asked to consider the next horizon in biological psychiatry and the delivery of evidence-based treatments. They have been asked to consider how the criminal justice system, mental healthcare system, disability sector and drug and alcohol services are interwoven and how to provide care that is integrated, and person centred.
Australian Health Journal spoke to current President-Elect Dr Elizabeth Moore and soon to be President, RANZCP about the Congress, as well as the recent Federal Budget announcements around mental health funding.
The RANZCP has welcomed a number of measures:
- $260.2 million over two years from 2023–24 to extend Commonwealth psychosocial supports for people with severe mental illness who are not in the National Disability Insurance Scheme (NDIS)
- $0.9 million over two years from 2022–23 to develop a 10 Year National Action Plan to support the health and wellbeing of Lesbian, Gay, Bisexual, Transgender, Intersex, Queer and Asexual (LGBTIQA+) people and establish a LGBTIQA+ Health Advisory Group.
- $40.0 million over 4 years from 2023–24 to establish the National Clinical Quality Registry Program for tracking the safety and performance of treatments and devices, thereby improving performance reporting for clinicians and hospitals.
- $4.9 billion over 5 years from 2022–23 (with $1.3 billion per year ongoing) to increase support for people receiving working age payments including the JobSeeker Payment. As noted in the College’s submission to the Senate Inquiry into poverty in Australia, we urged for an increase to the allowance rate for Australians accessing government-funded payments, including JobSeeker.
However, while there are some positive measures for mental health, RANZCP believe funding has been weighted to wellbeing initiatives and primary care. Australians experiencing the most serious mental health conditions, with severe, complex and chronic presentations have missed out on vital support in this year’s Federal Budget.
A particular group of concern is children. Around 3 in 4 children with a severe mental health disorder are missing out on critical support, according to Dr Moore.
Out of the 80,000 children in Australian with a severe mental health condition, only 22,000 are currently being seen by a psychiatrist, stating the case that more child and adolescent psychiatrists are needed to meet the needs of children.
You Might also like
-
Diversity, inclusion and equity New Content Orthopaedic Surgeon People in healthcare Workforce growth
Supporting women in arthroplasty, surgery & orthopaedic oncology
Associate Professor Claudia Di Bella is an academic orthopaedic surgeon based in Melbourne, specialising in orthopaedic oncology and complex joint reconstruction. Originally trained at the world-renowned Rizzoli Orthopaedic Institute (Istituto Ortopedico Rizzoli) in Bologna, Italy, she moved to Australia in 2010 and was awarded Fellowship of the Royal Australasian College of Surgeons in 2013.
-
New clinical research entity first to operate across both Australia and New Zealand
Over the past 30 years, 18,000 clinical trials that have been registered in Australia, with the sector contributing $1.4 billion to Australia’s economy annually. Trials are a critical aspect of evidence-based medicine, and are essential for testing how new treatments, tests and vaccines will work. In New Zealand they contribute $146 million to the New Zealand economy.
To capitalise on this unique position and growth, a coordinated multi-site clinical research operation was missing, until now.
-
Pathology technology at a crossroads
The CEO of Pathology Technology Australia, Dean Whiting spoke with Australian Health Journal about the following:
– Pathology Technology Australia’s key priorities in the coming years
– Current local capability in pathology technology compared to other countries
– How the health system supports change and adoption of pathology technology
– How pathology is perceived by the public and in government as well as how developments in pathology technology are followed and understood
– Observations in the Strengthening Medicare Taskforce ReportIn the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.